medigraphic.com
ISSN 3061-8142 (Electronic)

2026, Number 3

<< Back Next >>

Rev Mex Anest 2026; 49 (3)

Pain and anesthetic management in patients with rheumatoid arthritis

Zúñiga-Carmona VH, Cruz-Nocelo EJ, García-Reyes G, Vallejo-Villalobos ML, Nolasco-Ramírez AM, Piedra-Morales MB

Language: Spanish
References: 51
Page: 168-175
PDF size: 908.06 Kb.


ABSTRACT

Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory disease mediated by autoimmunity, which affects the joint synovial tissue. It can also include manifestations such as pleuritis, pulmonary restrictive processes, pericarditis, vasculitis, scleritis, glomerulonephritis, etc. During the pre-anesthetic and anesthetic assessment process we must consider: articular and extra-articular alterations, specific treatment, joint deformities, management of difficult airways and pain control. The AR and depression are disabling and negative conditions when they persist in the same individual, impacting the patient and family. The management of acute chronic pain and anesthesia in patients with rheumatoid arthritis is a challenge for health personnel.


REFERENCES

  1. Sebba A. Pain: a review of interleukin-6 and its roles in the pain of rheumatoid arthritis. Open Access Rheumatol. 2021;13:31-43. doi: 10.2147/OARRR.S291388.

  2. Cao Y, Fan D, Yin Y. Pain mechanism in rheumatoid arthritis: from cytokines to central sensitization. Mediators Inflamm. 2020;2020:2076328. Available in: https://doi.org/10.1155/2020/2076328

  3. Ravi K, Anshul A, Rinku R, Surajpal V. A review on pathophysiology of rheumatoid arthritis in conjunction with modernistic approaches of treatment. Plant Archives. 2019;19:2201-2206.

  4. Gamero D. Artritis reumatoide, epidemiología, fisiopatología, criterios diagnósticos y tratamiento. Revista de Medicina e Investigación Universidad Autónoma del Estado de México. 2018;6:53-61.

  5. Miguel-Lavariega D, Elizararrás-Rivas J, Villarreal-Ríos E, et al. Perfil epidemiológico de la artritis reumatoide [Epidemiological profile of rheumatoid arthritis]. Rev Med Inst Mex Seguro Soc. 2023;61:574-582. Spanish. doi: 10.5281/zenodo.8316427.

  6. Oliva-Gutiérrez E, Martínez-Godoy MP, Zapata-Zúñiga M, Sánchez-Rodríguez SH. Artritis Reumatoide: Prevalencia, inmunopatogenia y antígenos relevantes para su diagnóstico. Archivos de Medicina. 2012;8:3. doi: 10.3823/084.

  7. Sharif K, Sharif A, Jumah F, Oskouian R, Tubbs RS. Rheumatoid arthritis in review: clinical, anatomical, cellular and molecular points of view. Clin Anat. 2018;31:216-223. Available in: https://doi.org/10.1002/ca.22980

  8. Laquihuanaco F, Condori W, Mendoza E. Articulación temporomandibular: revisión general. Revista Peruana de Morfología, 2022;3:50-56. Disponible en: https//doi.org/10.51343/revperuanademorfología.v3il.830

  9. González S, Pacheco C, Campos R. Alteraciones temporomandibulares y odontológicas en pacientes con artritis reumatoide, Reumatol Clin. 2020;16:262-271. Disponible en: https://doi.org/10.1016/j.reuma.2018.07.005

  10. Schonenberger KA, Schüpfer AC, Gloy VL, et al. Effect of anti-inflammatory diets on pain in rheumatoid arthritis: a systematic review and meta-analysis. Nutrients. 2021;13:4221. doi: 10.3390/nu13124221.

  11. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205-2219. doi: 10.1056/NEJMra1004965.

  12. Ilchovska D, Barrow M. An Overview of the NF-kB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-kB ligand RANKL and related nutritional interventions. Autoimmun Rev. 2021;20:102741. doi: 10.1016/j.autrev.2020.102741.

  13. Shah P, Siddique A, Thakkar A. An update on novel therapeutic intervention in Rheumatoid arthritis. Int Immunopharmacol. 2022;109:108794. doi: 10.1016/j.intimp.2022.108794.

  14. Armas RWE, Alarcón MGA, Ocampo DFD, Arteaga CM, Arteaga PPA. Artritis reumatoide, diagnóstico, evolución y tratamiento. Rev Cuba de Reumatol. 2019;21:e114.

  15. Clavero LR, Navarro AAI, Ruiz HM, Urra AJM. Anti-péptidos citrulinados cíclicos y factor reumatoide en la artritis reumatoide. Actual Med. 2021;106:157-164. doi: 10.15568/am.2021.813.or02

  16. Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R. Extra-articular manifestations in rheumatoid arthritis. Maedica (Bucur). 2010;5:286-291.

  17. Latcha S, Gupta M, Lin IH, Jaimes EA. High dose methotrexate-induced acute kidney injury: incidence, risk factors, and recovery. Kidney Int Rep. 2022;8:360-364. doi: 10.1016/j.ekir.2022.10.029.

  18. Turesson C, McClelland RL, Christianson TJ, Matteson EL. Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis. 2007;66:70-75. doi: 10.1136/ard.2006.052506.

  19. Roman MJ, Moeller E, Davis A, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med. 2006;144:249-256. doi: 10.7326/0003-4819-144-4-200602210-00006. Erratum in: Ann Intern Med. 2006;145:868.

  20. Van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum. 2002;46:862-873. doi: 10.1002/art.10089.

  21. Apfelbaum JL, Hagberg CA, Connis RT, et al. 2022 American Society of Anesthesiologists practice guidelines for management of the difficult airway. Anesthesiology. 2022;136:31-81. doi: 10.1097/ALN.0000000000004002.

  22. Vieira E, Goodman S, Tanaka P, Anestesia y artritis reumatoide. Rev Bras Anestesiol. 2011;61:199-203. Disponible en: https://doi.org/10.1590/S0034-70942011000300013

  23. Tominaga A, Ikari K, Yano K, et al. Surgical intervention for patients with rheumatoid arthritis is declining except for foot and ankle surgery: a single-centre, 20-year observational cohort study. Mod Rheumatol. 2023;33:509-516. doi: 10.1093/mr/roac042.

  24. Momohara S, Yano K, Sakuma Y, Ikari K. Recent orthopedic surgeries aiming to improve quality of life for patients with rheumatoid arthritis. J Rheumatol. 2016;43:245. doi: 10.3899/jrheum.150238.

  25. Ishikawa H, Abe A, Kojima T, et al. Overall benefits provided by orthopedic surgical intervention in patients with rheumatoid arthritis. Mod Rheumatol. 2019;29:335-343. Available in: https://doi.org/10.1080/14397595.2018.1457468

  26. Simmen BR, Bogoch ER, Goldhahn J. Surgery insight: orthopedic treatment options in rheumatoid arthritis. Nat Clin Pract Rheumatol. 2008;4:266-273. doi: 10.1038/ncprheum0767.

  27. Nikiphorou E, Konan S, MacGregor AJ, Haddad FS, Young A. The surgical treatment of rheumatoid arthritis: a new era? Bone Joint J. 2014;96-B:1287-1289. doi: 10.1302/0301-620X.96B10.34506.

  28. Bullock J, Rizvi SAA, Saleh AM, et al. Rheumatoid arthritis: a brief overview of the treatment. Med Princ Pract. 2018;27:501-507. doi: 10.1159/000493390.

  29. Anderson RJ. Controversy in the surgical treatment of the rheumatoid hand. Hand Clin 2011; 27(1): 21-25. doi: 10.1016/j.hcl.2010.10.007

  30. Shim JW, Park MJ. Arthroscopic synovectomy of wrist in rheumatoid arthritis. Hand Clin 2017;33:779-785. doi: 10.1016/j.hcl.2017.07.005

  31. Kirwan MJ, Johnson EP, Calkins TE, Holland CT, Mihalko WM, Ford MC. Total joint arthroplasty in the patient with inflammatory arthritis: a review. Orthop Clin North Am. 2024;55:425-434. doi: 10.1016/j.ocl.2024.04.001.

  32. Oprea AD, Keshock MC, O'Glasser AY, et al. Preoperative management of medications for neurologic diseases: society for perioperative assessment and quality improvement consensus statement. Mayo Clin Proc. 2022;97:375-396. doi: 10.1016/j.mayocp.2021.11.010.

  33. Woodcock T, Barker P, Daniel S, et al. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia. 2020;75:654-663. doi: 10.1111/anae.14963. Epub 2020 Feb 3. Erratum in: Anaesthesia. 2020;75:1252. doi: 10.1111/anae.15210.

  34. Wang AS, Armstrong EJ, Armstrong AW. Corticosteroids and wound healing: clinical considerations in the perioperative period. Am J Surg. 2013;206:410-417. doi: 10.1016/j.amjsurg.2012.11.018.

  35. Moore N, Pollack C, Butkerait P. Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag. 2015;11:1061-1075. doi: 10.2147/TCRM.S79135.

  36. Liu MM, Reidy AB, Saatee S, Collard CD. Perioperative steroid management: approaches based on current evidence. Anesthesiology. 2017;127:166-172. doi: 10.1097/ALN.0000000000001659.

  37. Chukir T, Goodman SM, Tornberg H, et al. Perioperative glucocorticoids in patients with rheumatoid arthritis having total joint replacements: help or harm? ACR Open Rheumatol. 2021;3:654-659. doi: 10.1002/acr2.11306.

  38. Scanzello CR, Figgie MP, Nestor BJ, Goodman SM. Perioperative management of medications used in the treatment of rheumatoid arthritis. HSS J. 2006;2:141-147. doi: 10.1007/s11420-006-9012-5.

  39. Kim HR, Kim SH. Perioperative and anesthetic management of patients with rheumatoid arthritis. Korean J Intern Med. 2022;37:732-739. doi: 10.3904/kjim.2021.555

  40. Caracci B, Aranda F. Síndrome de infusión por propofol en el adulto. Rev Chil Anest. 2018;47:189-195. Disponible en: https://doi.org/10.25237/revchilanestv47n03.05

  41. Raja SN, Carr DB, Cohen M, et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161:1976-1982. doi: 10.1097/j.pain.0000000000001939.

  42. Sambamoorthi U, Shah D, Zhao X. Healthcare burden of depression in adults with arthritis. Expert Rev Pharmacoecon Outcomes Res. 2017;17:53-65. doi: 10.1080/14737167.2017.1281744.

  43. Guamba LJMMA, Herrera GRJ, Gallardo ASG, et al. Manejo del dolor en el postoperatorio de cirugías articulares. Nuevos enfoques. Rev Cuba Reumatol. 2019;21:1-11. Disponible en: http://dx.doi.org/10.5281/zenodo.2555861

  44. Atkinson TJ, Fudin J. Nonsteroidal antiinflammatory drugs for acute and chronic pain. Phys Med Rehabil Clin N Am. 2020;31:219-231. doi: 10.1016/j.pmr.2020.01.002.

  45. Kychenthal LC, Vega PE, Elgueta LF. Consideraciones en pacientes con dolor crónico sometidos a cirugía. Rev Cir. 2020;72:597-602. doi: 10.35687/s2452-45492020006978

  46. Smith PP, Chicca IJ, Heaney JLJ, et al. Paracetamol suppresses neutrophilic oxygen radicals through competitive inhibition and scavenging. Chem Biol Interact. 2024;404:111283. Available in: https://doi.org/10.1016/j.cbi.2024.111283

  47. Lavand'homme PM, Kehlet H, Rawal N, et al. Pain management after total knee arthroplasty: PROcedure SPEcific Postoperative Pain ManagemenT recommendations. Eur J Anaesthesiol. 2022;39:743-757. doi: 10.1097/EJA.0000000000001691.

  48. Williams BS, Buvanendran A. Nonopioid adjuvants in multimodal therapy for acute perioperative pain. Adv Anesth. 2009;27:111-142. doi: 10.1016/j.aan.2009.07.008.

  49. Verret M, Lauzier F, Zarychanski R, et al. Perioperative use of gabapentinoids for the management of postoperative acute pain: a systematic review and meta-analysis. Anesthesiology. 2020;133:265-279. doi: 10.1097/ALN.0000000000003428. Erratum in: Anesthesiology. 2020 Nov 1;133(5):1159. doi: 10.1097/ALN.0000000000003549.

  50. Kumar AH, Habib AS. The role of gabapentinoids in acute and chronic pain after surgery. Curr Opin Anaesthesiol. 2019;32:629-634. doi: 10.1097/ACO.0000000000000767.

  51. Edinoff AN, Askins D, Bobo E, et al. The emerging role of ketamine in acute postoperative pain management. Curr Pain Headache Rep. 2023;27:387-397. doi: 10.1007/s11916-023-01134-1.




2020     |     www.medigraphic.com